{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T02:54:24Z","timestamp":1792896864260,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T00:00:00Z","timestamp":1581638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Plasma trimethylamine N-oxide (TMAO) is associated with coronary atherosclerotic plaque and cardiovascular disease risk, but associations between gut microbes in acute coronary syndrome (ACS) and post-ST-segment elevation myocardial infarction (post-STEMI) events are unknown. We investigated associations between gut microbial taxa and systemic TMAO levels and the possible TMAO contribution to incident post-STEMI cardiovascular events. Patients and Methods. A total of 60 patients, including 30 with unstable angina pectoris (UAP), 30 post-STEMI and 30 healthy controls, were enrolled from June to November 2017. Metagenomic sequencing was performed and TMAO and IL-6 were detected. Results. Minimal discriminators of gut microbial taxa (top 40) distinguished ACS patients from controls. Serum TMAO levels were positively associated with increased abundance of <jats:italic>Aerococcaceae, Ruminococcaceae_UCG.005, Ruminococcaceae_UCC.014<\/jats:italic> and <jats:italic>X. Eubacterium_fissicatena<\/jats:italic>, and decreased abundance of <jats:italic>Lachnospiraceae_FCS020<\/jats:italic> (P\u2009&lt;\u20090.05). Elevated serum TMAO levels correlated independently with ACS (P\u2009&lt;\u20090.05). Risk stratification for incident major adverse cardiovascular events (MACE) improved at one year in patients with serum TMAO levels \u22662.19\u2009\u00b5M. Serum interleukin-6 levels were not significantly increased in patients with ACS and post-STEMI MACE. Conclusions. ACS and incident post-STEMI MACE may be associated with the gut bacteria choline metabolite TMAO. The specific gut microbial taxa identified in association with serum TMAO levels may be potential predictive biomarkers for accurate diagnosis of ACS onset.<\/jats:p>","DOI":"10.1038\/s41598-020-59235-5","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T11:03:14Z","timestamp":1581678194000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Gut microbial taxa as potential predictive biomarkers for acute coronary syndrome and post-STEMI cardiovascular events"],"prefix":"10.1038","volume":"10","author":[{"given":"Jing","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun-Tao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Xiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,14]]},"reference":[{"key":"59235_CR1","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1007\/s00395-014-0444-7","volume":"109","author":"V Kain","year":"2014","unstructured":"Kain, V., Prabhu, S. D. & Halade, G. V. Inflammation revisited: inflammation versus resolution of inflammation following myocardial infarction. Basic. Res. Cardiol. 109, 444 (2014).","journal-title":"Basic. Res. Cardiol."},{"key":"59235_CR2","first-page":"1","volume":"65","author":"M Heron","year":"2016","unstructured":"Heron, M. Deaths: Leading Causes for 2013. Natl Vital. Stat. Rep. 65, 1\u201395 (2016).","journal-title":"Natl Vital. Stat. Rep."},{"key":"59235_CR3","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1161\/CIRCRESAHA.114.302782","volume":"114","author":"R Vedanthan","year":"2014","unstructured":"Vedanthan, R., Seligman, B. & Fuster, V. Global perspective on acute coronary syndrome: a burden on the young and poor. Circ. Res. 114, 1959\u20131975 (2014).","journal-title":"Circ. Res."},{"key":"59235_CR4","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"NG Frangogiannis","year":"2012","unstructured":"Frangogiannis, N. G. Regulation of the inflammatory response in cardiac repair. Circ. Res. 110, 159\u2013173 (2012).","journal-title":"Circ. Res."},{"key":"59235_CR5","doi-asserted-by":"publisher","first-page":"15718","DOI":"10.1073\/pnas.0407076101","volume":"101","author":"F B\u00e4ckhed","year":"2004","unstructured":"B\u00e4ckhed, F. et al. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl Acad. Sci. USA 101, 15718\u201315723 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59235_CR6","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1038\/nature05414","volume":"444","author":"PJ Turnbaugh","year":"2006","unstructured":"Turnbaugh, P. J. et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 444, 1027\u20131031 (2006).","journal-title":"Nature."},{"key":"59235_CR7","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","volume":"158","author":"LM Cox","year":"2014","unstructured":"Cox, L. M. et al. Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences. Cell. 158, 705\u2013721 (2014).","journal-title":"Cell."},{"key":"59235_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 472, 57\u201363 (2011).","journal-title":"Nature."},{"key":"59235_CR9","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/nm.3145","volume":"19","author":"RA Koeth","year":"2013","unstructured":"Koeth, R. A. et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat. Med. 19, 576\u2013585 (2013).","journal-title":"Nat. Med."},{"key":"59235_CR10","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","volume":"368","author":"WH Tang","year":"2013","unstructured":"Tang, W. H. et al. Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk. N. Engl. J. Med. 368, 1575\u20131584 (2013).","journal-title":"N. Engl. J. Med."},{"key":"59235_CR11","doi-asserted-by":"publisher","first-page":"5647","DOI":"10.1074\/jbc.M114.618249","volume":"290","author":"JC Gregory","year":"2015","unstructured":"Gregory, J. C. et al. Transmission of atherosclerosis susceptibility with gut microbial transplantation. J. Biol. Chem. 290, 5647\u20135660 (2015).","journal-title":"J. Biol. Chem."},{"key":"59235_CR12","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","volume":"165","author":"W Zhu","year":"2016","unstructured":"Zhu, W. et al. Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis Risk. Cell. 165, 111\u2013124 (2016).","journal-title":"Cell."},{"key":"59235_CR13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cmet.2012.12.011","volume":"17","author":"BJ Bennett","year":"2013","unstructured":"Bennett, B. J. et al. Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab. 17, 49\u201360 (2013).","journal-title":"Cell Metab."},{"key":"59235_CR14","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1093\/eurheartj\/ehu002","volume":"35","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. Prognostic value of choline and betaine depends on intestinal microbiota-generated metabolite trimethylamine-N-oxide. Eur. Heart J. 35, 904\u2013910 (2014).","journal-title":"Eur. Heart J."},{"key":"59235_CR15","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.jacc.2014.02.617","volume":"64","author":"WH Tang","year":"2014","unstructured":"Tang, W. H. et al. Prognostic value of elevated levels of intestinal microbe-generated metabolite trimethylamine-N-oxide in patients with heart failure: refining the gut hypothesis. J. Am. Coll. Cardiol. 64, 1908\u20131914 (2014).","journal-title":"J. Am. Coll. Cardiol."},{"key":"59235_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-018-0441-4","volume":"6","author":"X Zhou","year":"2018","unstructured":"Zhou, X. et al. Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction. Microbiome. 6, 66 (2018).","journal-title":"Microbiome."},{"key":"59235_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7498","volume":"6","author":"J Miao","year":"2015","unstructured":"Miao, J. et al. Flavin-containing monooxygenase 3 as a potential player in diabetes-associated atherosclerosis. Nat. Commun. 6, 6498 (2015).","journal-title":"Nat. Commun."},{"key":"59235_CR18","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1194\/jlr.M051680","volume":"56","author":"DM Shih","year":"2015","unstructured":"Shih, D. M. et al. Flavin containing monooxygenase 3 exerts broad effects on glucose and lipid metabolism and atherosclerosis. J. Lipid Res. 56, 22\u201337 (2015).","journal-title":"J. Lipid Res."},{"key":"59235_CR19","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.celrep.2014.12.036","volume":"10","author":"M Warrier","year":"2015","unstructured":"Warrier, M. et al. The TMAO-Generating Enzyme Flavin Monooxygenase 3 Is a Central Regulator of Cholesterol Balance. Cell Rep. 10, 326\u2013338 (2015).","journal-title":"Cell Rep."},{"key":"59235_CR20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","volume":"116","author":"WH Tang","year":"2015","unstructured":"Tang, W. H. et al. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Circ. Res. 116, 448\u2013455 (2015).","journal-title":"Circ. Res."},{"key":"59235_CR21","doi-asserted-by":"publisher","first-page":"e114969","DOI":"10.1371\/journal.pone.0114969","volume":"9","author":"M Lever","year":"2014","unstructured":"Lever, M. et al. Betaine and Trimethylamine-N-Oxide as Predictors of Cardiovascular Outcomes Show Different Patterns in Diabetes Mellitus: An Observational Study. PLoS One. 9, e114969 (2014).","journal-title":"PLoS One."},{"key":"59235_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-48246-6","volume":"9","author":"Y Matsuzawa","year":"2019","unstructured":"Matsuzawa, Y. et al. Microbiota-derived trimethylamine N-oxide predicts cardiovascular risk after STEMI. Sci. Rep. 9, 11647 (2019).","journal-title":"Sci. Rep."},{"issue":"1","key":"59235_CR23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.14806\/ej.17.1.200","volume":"17","author":"Marcel Martin","year":"2011","unstructured":"Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. Embnet Journal. 17, 10.10.14806\/ej.17.1.200 (2011).","journal-title":"EMBnet.journal"},{"key":"59235_CR24","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1093\/bioinformatics\/btr381","volume":"27","author":"RC Edgar","year":"2011","unstructured":"Edgar, R. C., Haas, B. J., Clmente, J. C., Quince, C. & Knight, R. UCHIME improves sensitivity and speed of chimera detection. Bioinformatics. 27, 2194\u20132200 (2011).","journal-title":"Bioinformatics."},{"key":"59235_CR25","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1101\/gr.112730.110","volume":"21","author":"BJ Haas","year":"2011","unstructured":"Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 21, 494\u2013504 (2011).","journal-title":"Genome Res."},{"key":"59235_CR26","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1038\/nmeth.2604","volume":"10","author":"RC Edgar","year":"2013","unstructured":"Edgar, R. C. UPARSE: highly accurate OTU sequences from microbial amplicon reads. Nat. Methods. 10, 996\u2013998 (2013).","journal-title":"Nat. Methods."},{"issue":"4","key":"59235_CR27","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11596-017-1767-z","volume":"37","author":"Hao Li","year":"2017","unstructured":"Li H, et al. Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley rats. J Huazhong Univ Sci Technolog Med Sci. 37, 523-530","journal-title":"Journal of Huazhong University of Science and Technology [Medical Sciences]"},{"key":"59235_CR28","doi-asserted-by":"publisher","first-page":"4299","DOI":"10.1039\/C8FO00349A","volume":"9","author":"L Qiu","year":"2018","unstructured":"Qiu, L., Tao, X., Xiong, H., Yu, J. & Wei, H. Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice. Food Funct. 9, 4299\u20134309 (2018).","journal-title":"Food Funct."},{"issue":"9","key":"59235_CR29","doi-asserted-by":"publisher","first-page":"e028211","DOI":"10.1136\/bmjopen-2018-028211","volume":"26","author":"K Yao","year":"2019","unstructured":"Yao, K. et al. Effect of combined testing of ceramides with high-sensitive troponin T on the detection of acute coronary syndrome in patients with chest pain in China a prospective observational study. BMJ Open. 26(9), e028211 (2019).","journal-title":"BMJ Open."},{"key":"59235_CR30","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1093\/eurheartj\/ehv428","volume":"36","author":"N Townsend","year":"2015","unstructured":"Townsend, N. et al. Cardiovascular disease in Europe\u2013epidemiological update 2015. Eur. Heart J. 36, 2696\u20137205 (2015).","journal-title":"Eur. Heart J."},{"key":"59235_CR31","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2015.05.035","volume":"241","author":"E Org","year":"2015","unstructured":"Org, E., Mehrabian, M. & Lusis, A. J. Unraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota. Atherosclerosis. 241, 387\u2013399 (2015).","journal-title":"Atherosclerosis."},{"key":"59235_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1111\/joim.12328","volume":"277","author":"M Troseid","year":"2015","unstructured":"Troseid, M. et al. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure. J. Intern. Med. 277, 717\u2013726 (2015).","journal-title":"J. Intern. Med."},{"key":"59235_CR33","first-page":"814","volume":"38","author":"XS Li","year":"2017","unstructured":"Li, X. S. et al. Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors. Eur. Heart J. 38, 814\u2013824 (2017).","journal-title":"Eur. Heart J."},{"key":"59235_CR34","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1373\/clinchem.2016.264853","volume":"63","author":"T Suzuki","year":"2017","unstructured":"Suzuki, T., Heaney, L. M., Jones, D. J. & Ng, L. L. Trimethylamine N-oxide and Risk Stratification after Acute Myocardial Infarction. Clin. Chem. 63, 420\u2013428 (2017).","journal-title":"Clin. Chem."},{"key":"59235_CR35","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/j.cell.2015.11.055","volume":"163","author":"Z Wang","year":"2015","unstructured":"Wang, Z. et al. Non-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of Atherosclerosis. Cell. 163, 1585\u20131595 (2015).","journal-title":"Cell."},{"key":"59235_CR36","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1007\/s00216-015-9164-6","volume":"408","author":"LM Heaney","year":"2016","unstructured":"Heaney, L. M., Jones, D. J., Mbasu, R. J., Ng, L. L. & Suzuki, T. High mass accuracy assay for trimethylamine N-oxide using stable-isotope dilution with liquid chromatography coupled to orthogonal acceleration time of flight mass spectrometry with multiple reaction monitoring. Anal. Bioanal. Chem. 408, 797\u2013804 (2016).","journal-title":"Anal. Bioanal. Chem."},{"key":"59235_CR37","doi-asserted-by":"publisher","unstructured":"Senthong V, et al. Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort. J Am Heart Assoc. 5, https:\/\/doi.org\/10.1161\/JAHA.115.002816 (2016).","DOI":"10.1161\/JAHA.115.002816"},{"key":"59235_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1681\/ASN.2016030374","volume":"28","author":"T Shafi","year":"2017","unstructured":"Shafi, T. et al. Trimethylamine N-Oxide and Cardiovascular Events in Hemodialysis Patients. J. Am. Soc. Nephrol. 28, 321\u2013331 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"59235_CR39","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1053\/j.jrn.2015.02.006","volume":"25","author":"GA Kaysen","year":"2015","unstructured":"Kaysen, G. A. et al. Associations of Trimethylamine N-Oxide with Nutritional and Inflammatory Biomarkers and Cardiovascular Outcomes in Patients New to Dialysis. J. Ren. Nutr. 25, 351\u2013356 (2015).","journal-title":"J. Ren. Nutr."},{"key":"59235_CR40","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/j.atherosclerosis.2015.10.091","volume":"243","author":"DM Mueller","year":"2015","unstructured":"Mueller, D. M. et al. Plasma levels of trimethylamine-N-oxide are confounded by impaired kidney function and poor metabolic control. Atherosclerosis. 243, 638\u2013644 (2015).","journal-title":"Atherosclerosis."},{"key":"59235_CR41","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1161\/CIRCULATIONAHA.105.579979","volume":"113","author":"SJ Ott","year":"2006","unstructured":"Ott, S. J. et al. Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation. 113, 929\u2013937 (2006).","journal-title":"Circulation."},{"key":"59235_CR42","doi-asserted-by":"publisher","first-page":"4592","DOI":"10.1073\/pnas.1011383107","volume":"108","author":"O Koren","year":"2011","unstructured":"Koren, O. et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc. Natl Acad. Sci. USA 108, 4592\u20134598 (2011).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"59235_CR43","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1096\/fj.11-197921","volume":"26","author":"V Lam","year":"2012","unstructured":"Lam, V. et al. Intestinal microbiota determine severity of myocardial infarction in rats. FASEB J. 26, 1727\u20131735 (2012).","journal-title":"FASEB J."},{"key":"59235_CR44","doi-asserted-by":"publisher","first-page":"e0160840","DOI":"10.1371\/journal.pone.0160840","volume":"11","author":"V Lam","year":"2016","unstructured":"Lam, V. et al. Intestinal Microbial Metabolites Are Linked to Severity of Myocardial Infarction in Rats. PLoS One. 11, e0160840 (2016).","journal-title":"PLoS One."},{"key":"59235_CR45","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1161\/CIRCHEARTFAILURE.113.000978","volume":"7","author":"XT Gan","year":"2014","unstructured":"Gan, X. T. et al. Probiotic administration attenuates myocardial hypertrophy and heart failure after myocardial infarction in the rat. Circ. Heart Fail. 7, 491\u2013499 (2014).","journal-title":"Circ. Heart Fail."},{"key":"59235_CR46","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1161\/01.CIR.0000027820.66786.CF","volume":"106","author":"AF Stone","year":"2002","unstructured":"Stone, A. F. et al. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA). Circulation. 106, 1219\u20131223 (2002).","journal-title":"Circulation."},{"key":"59235_CR47","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1253\/circj.CJ-15-0526","volume":"79","author":"T Yamashita","year":"2015","unstructured":"Yamashita, T. et al. Intestinal Immunity and Gut Microbiota as Therapeutic Targets for Preventing Atherosclerotic Cardiovascular Diseases. Circ. J. 79, 1882\u20131890 (2015).","journal-title":"Circ. J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59235-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59235-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T06:57:21Z","timestamp":1670309841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-59235-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,14]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["59235"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-59235-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,14]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2639"}}